These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16702733)

  • 21. [Effect of a leukotriene antagonist, pranlukast hydrate, on exercise-induced asthma for 14 days].
    Suguro H; Majima T; Hattori T; Ichimura K; Hashimoto N; Horie T
    Arerugi; 2000 Aug; 49(8):646-52. PubMed ID: 11021016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduced basal salivary cortisol in children with asthma and allergic rhinitis.
    Bakkeheim E; Mowinckel P; Carlsen KH; Burney P; Lødrup Carlsen KC
    Acta Paediatr; 2010 Nov; 99(11):1705-11. PubMed ID: 19912147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method.
    Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years.
    Jullien V; Urien S; Hirt D; Delaugerre C; Rey E; Teglas JP; Vaz P; Rouzioux C; Chaix ML; Macassa E; Firtion G; Pons G; Blanche S; Tréluyer JM
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3548-55. PubMed ID: 16940058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.
    Nakamura Y; Hoshino M; Sim JJ; Ishii K; Hosaka K; Sakamoto T
    Thorax; 1998 Oct; 53(10):835-41. PubMed ID: 10193369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a prior authorization policy for montelukast on clinical outcomes for asthma and allergic rhinitis among children and adolescents in a state Medicaid program.
    Keast SL; Thompson D; Farmer K; Smith M; Nesser N; Harrison D
    J Manag Care Spec Pharm; 2014 Jun; 20(6):612-21. PubMed ID: 24856599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K; Hashiguchi K; Kanzaki S; Fujioka M; Tanaka N; Kawashima K; Suematsu K; Yamamotoya H; Iwasaki M; Gotoh M; Horibe S; Naito K; Okubo K
    Allergy Asthma Proc; 2012; 33(1):102-9. PubMed ID: 22370535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma.
    Horiguchi T; Tachikawa S; Kondo R; Miyazaki J; Shiga M; Hirose M; Kobayashi K; Hayashi N; Ohira D; Nasu T; Otake Y; Hata H
    Arzneimittelforschung; 2007; 57(2):87-91. PubMed ID: 17396618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y; Shimoda T; Tomari SY; Mitsuta K; Kawano T; Matsuse H; Kohno S
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of switching low-dose inhaled corticosteroid to pranlukast for step-down therapy in well-controlled patients with mild persistent asthma.
    Harada S; Harada N; Itoigawa Y; Katsura Y; Kasuga F; Ishimori A; Makino F; Ito J; Atsuta R; Takahashi K
    J Asthma; 2016; 53(2):207-12. PubMed ID: 26325232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of the leukotriene receptor antagonist pranlukast hydrate for the treatment of sleep disorder in patients with perennial allergic rhinitis.
    Hara H; Sugahara K; Hashimoto M; Mikuriya T; Tahara S; Yamashita H
    Acta Otolaryngol; 2014 Mar; 134(3):307-13. PubMed ID: 24460152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical effects of long-term administration of pranlukast, a leukotriene receptor antagonist, on adult patients with bronchial asthma].
    Horiguchi T; Kondo R; Miyazaki J; Shiga M; Sugiyama M; Hirose M; Tachikawa S
    Nihon Kokyuki Gakkai Zasshi; 2003 Oct; 41(10):696-703. PubMed ID: 14584388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of pulmonary function in bronchial asthma patients treated with pranlukast.
    Yanagawa H; Sugita A; Azuma M; Ogawa H; Kitamuro C; Yoneda K; Shinkawa K; Tani K; Sone S
    Lung; 2004; 182(1):51-8. PubMed ID: 14752672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenge studies of a leukotriene receptor antagonist.
    Okudaira H
    Chest; 1997 Feb; 111(2 Suppl):46S-51S. PubMed ID: 9042026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers.
    Brocks DR; Upward JW; Georgiou P; Stelman G; Doyle E; Allen E; Wyld P; Dennis MJ
    Eur J Clin Pharmacol; 1996; 51(3-4):303-8. PubMed ID: 9010703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of Solubility, Transport Across Madin-Darby Canine Kidney Monolayers and Oral Absorption of Pranlukast Through Preparation of a Pranlukast-Phospholipid Complex.
    Hao Y; Wang L; Li J; Liu N; Feng J; Zhao M; Zhang X
    J Biomed Nanotechnol; 2015 Mar; 11(3):469-77. PubMed ID: 26307829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of response to long-term treatment with Pranlukast in patients with bronchial asthma.
    Niitsuma T; Izawa J; Maruoka N; Nukaga M; Tsuji A; Okita M; Sakurai K; Morita S; Tsuyuguchi M; Matsumura Y; Hayashi T
    J Investig Allergol Clin Immunol; 2004; 14(4):284-91. PubMed ID: 15736713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlations of health-related quality of life questionnaire results in asthma and allergic rhinitis: effects of a leukotriene receptor antagonist.
    Ichimaru Y; Kanazawa H; Kamoi H; Kyoh S; Tochino Y; Kodama T; Hirata K
    J Int Med Res; 2008; 36(3):559-66. PubMed ID: 18534139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early- and late-phase bronchoconstriction and airway hyperresponsiveness in asthmatic subjects.
    Hamilton A; Faiferman I; Stober P; Watson RM; O'Byrne PM
    J Allergy Clin Immunol; 1998 Aug; 102(2):177-83. PubMed ID: 9723658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation.
    Yasui H; Fujisawa T; Inui N; Kato M; Hashimoto D; Enomoto N; Nakamura Y; Shirai T; Suda T; Nakamura H; Chida K
    Respir Med; 2012 Apr; 106(4):508-14. PubMed ID: 22265857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.